It is exciting to be a part of the incredible transformation underway in the healthcare sector and I work passionately to help clients achieve exceptional results.
Michael is a member of Lincoln’s Healthcare Group and leads the firm’s Healthcare Information Technology (HCIT) practice. He advises private equity clients, publicly traded companies and privately held businesses on mergers and acquisitions, as well as equity and debt capital raises. With close to two decades of experience in the industry, Michael has developed deep domain expertise and strong industry relationships across the sector. Michael has completed over 40 transactions in the healthcare sector for some of the most prominent companies in the industry.
The Healthcare sector is rapidly evolving as the adoption of technology such as software, data and analytics seek to improve patient outcomes while reducing overall cost and complexity. Michael’s understanding of the healthcare continuum, and how all constituents, patients, providers, payors and life sciences businesses are embracing technology, leads to exceptional outcomes for his clients.
Prior to joining Lincoln, Michael was at Houlihan Lokey where he helped lead the firm’s Healthcare Information Technology team. Previously, Michael worked as a Director at Deutsche Bank in the Healthcare Investment Banking group.
Michael earned a Bachelor of Science in finance from Villanova University.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)
Perspectives by Michael Siano
Interim/Post-COVID-19 Sector Outlook: Services & Products for Homebound Patients
Click the home healthcare sectors below to view key takeaways on the effects of COVID-19. Medical and Personal Services Skilled Home Healthcare Near term: REASONABLY STABLE / POSITIVE Long term: POSITIVE / […]
COVID-19 Pandemic Could Accelerate Recent U.S. Healthcare Growth Trends
One hundred years after the 1918 Spanish Flu, the world is facing another pandemic: COVID-19. Government and healthcare officials are working around the clock to flatten the curve and slow the spread […]
Q&A: Identifying the Non-Cyclical Sectors Most Resistant to a Potential Recession
Original post from Pitchbook on December 5, 2019 here. […]